Basic Information
LncRNA/CircRNA Name | circ_0000144 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | bladder cancer |
ICD-0-3 | C67 |
Methods | Cell proliferation assay, Transwell invasion assay, qRT-PCR, Cell cycle analysis, Luciferase reporter assay, Xenografts in mice, IHC analysis |
Sample | bladder cancer tissues, Bladder cancer cell lines (T24, EJ, UMUC3, RT4 and 253J) and SV-HUC-1 cells |
Expression Pattern | up-regulated |
Function Description | hsa_circ_0000144 expression was significantly upregulated in bladder cancer tissues compared with adjacent normal tissues, and its high expression was related with poor prognosis. Additionally, knockdown of hsa_circ_0000144 remarkably suppressed the proliferation and invasion of bladder cancer cells in vitro. Hsa_circ_0000144 silence also led to reduced tumor volumes in vivo. In mechanism, we found that hsa_circ_0000144 was a sponge of miR-217 while miR-217 targeted RUNX2. Our results indicated that the expression of miR-217 was inversely correlated with that of both hsa_circ_0000144 and RUNX2 in bladder cancer tissues. Rescue assays showed that either inhibition of miR-217 or restoration of RUNX2 reversed the suppressive effects of hsa_circ_0000144 knockdown on bladder cancer cell proliferation and invasion. |
Pubmed ID | 30098434 |
Year | 2018 |
Title | Downregulation of circular RNA hsa_circ_0000144 inhibits bladder cancer progression via stimulating miR-217 and suppressing RUNX2 expression |
External Links
Links for circ_0000144 | GenBank HGNC NONCODE |
Links for bladder cancer | OMIM COSMIC |